Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
November 9, 2025Oncology,clinical trials,Regulatory,AI in healthcare,immunology,biopharma,Lucid Diligence Brief,payer access,diligence,partnershipsde novo proteins
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Lumonus A$25M Series B
November 8, 2025digital health,reimbursement,Regulatory,AI in healthcare,biopharma,Lucid Diligence Brief,payer access,diligence,oncology operations,clinical workflowsradiation oncology
Lucid Diligence Brief: Lumonus A$25M Series B Professional audiences only. Not…
AHA 2025 Preview: Key Cardiovascular Highlights to Watch
November 7, 2025cardiovascular science,arrhythmias,Our Insights,lipids,AI,atherosclerosis,machine learning,CAD,obesity,prevention,HEART FAILURE,diabetes,Atrial fibrillation,hypertension,stroke,American Heart Association,PAD,Structural heart diseaseConference Previews,AHA 2025
AHA 2025 at a glance Get ready for AHA 2025 with LucidQuest’s concise preview.…
Respiratory Today—November 7, 2025
November 7, 2025COPD,BioPharma and Tech News,INOVIO,Idiopathic Pulmonary Fibrosis,Endeavor BioMedicines,Respiratory News,Recurrent respiratory papillomatosis,Tobramycin,TaladegibRitedose,Epithelial biology
This week’s respiratory update spotlights key developments, regulatory…
Vaccines Today—November 7, 2025
November 7, 2025takeda,BioPharma and Tech News,Dengue Vaccine,COVID-19 vaccine,Valneva,GC Biopharma,Vaccine news,Zika vaccine,Paratyphoid vaccine,Anthrax vaccineNeoantigen vaccine,Mucosal immunity
Get up to speed with this week’s Vaccine Research news, featuring clinical…
Public Health Video Recap—November 7, 2025
November 7, 2025HIV,BioPharma and Tech News,melanoma,Parkinson's Disease,Cardiovascular Disease,COVID-19,stroke,shingles,Public Health News,influenza,hepatitis C,oral healthmrsa infection,vre infection
🎯 Watch Our Video Summary Capturing Public Health News from the Last Two Weeks…
Public Health Today—7 November , 2025
November 7, 2025Alzheimer's Disease,BioPharma and Tech News,Colorectal Cancer,HEART FAILURE,Ischemic Stroke,World Health Organization,American Heart Association,Public Health NewsMetastatic melanoma,Periodontal disease
Your weekly public health summary: latest developments, studies, surveys and…
Lucid Diligence Brief: Amae Health $25M Series B
November 7, 2025digital health,market access,reimbursement,behavioral health,AI in healthcare,biopharma,Lucid Diligence Brief,payer access,diligence,venture fundingclinical outcomes
Lucid Diligence Brief: Amae Health $25M Series B Professional audiences only.…
Cell and Gene Therapy Today—November 6, 2025
November 6, 2025Duchenne Muscular Dystrophy,Huntington's disease,ophthalmology,Sickle Cell Disease,BioPharma and Tech News,CAR T Therapy,Cell and Gene Therapy News,AI in drug discoveryAAV vector,FDA gene therapy review
This week’s cell and gene therapy update spotlights key developments,…
Rare Disease Video Recap—November 6, 2025
November 6, 2025Elfabrio,TK2 deficiency,astrazeneca,novartis,ucb,Duchenne Muscular Dystrophy,BioPharma and Tech News,Avidity Biosciences,Alexion,Rare Disease News,Chiesi,myotonic dystrophy type 1,facioscapulohumeral muscular dystrophy,KygevviThymidine kinase 2 deficiency,Protalix
🎯 Watch Our Video Summary Capturing Rare Disease News from the Last Two Weeks…
Rare Disease Today—November 6, 2025
November 6, 2025astrazeneca,BioPharma and Tech News,Orphan Drugs,Idiopathic Pulmonary Fibrosis,Alexion,MHRA,Rare Disease News,Rare disease regulation,Elfabrio (pegunigalsidase alfa),KygevviThymidine kinase 2 deficiency,FDA orphan designation
This week’s Rare Disease Update covers pivotal rare-disease developments and…
Cardiovascular Video Recap—November 6, 2025
November 6, 2025wegovy,semaglutide,BioPharma and Tech News,hypertension,Medtronic,Cardiovascular News,Ancora Heart,Structural heart disease,Ventyx,TerumoOpuswave,coronary artery disease
🎯 Watch Our Video Summary Capturing Cardiovascular News from the Last Two……







